Nosocomial Infection in SARS COV-2 Pandemic
In SARS COV-2 pandemic, the healthcare facilities are the most actively functioning setups which are the critical (microbiologically) areas. Due to these facilities patients were benefitted but during this time many health care providers suffered from nosocomial infection and many were complaining about the spread of nosocomial infection. Hospitals and healthcare facilities are easy place for contacting with infection, but the spread of infection should be stopped by taking proper disinfection measures.
Introduction
The severe acute respiratory syndrome coronavirus 2 (SARSCoV-2), a novel strain of human coronavirus has spread over the world since its first case was reported from Wuhan, China in December 2019 and quickly this virus infected people from all over the world. When persons got infected with COVID-19 they produce symptoms like fatigue, fever, sore throat, congested chest, dyspnea, and diarrhoea, coughing up phlegm or blood, cough or sneeze and they release respiratory droplets that carry the virus causing the disease. Healthcare facilities are struggling to keep up with the influx of patients due to the rapidly deteriorating global economy. There have been some cases of transmission through faeces or direct contact, but the majority of human- to-human transmission happens through aerosols. According to the China CDC’s findings, the incubation period typically lasts one to three week of time period. The pandemic spreads across the world in short period of time. Although different infection prevention procedures were followed still, the infection cannot be stopped. All around the world many researchers working on the infection prevention criteria to provide the best protocol to prevent particular infection. This disease has initiated alertness and increase readiness for active prevention and control of infection. This can be done by wearing personal protective equipment (PPE), hygienic and disinfection measures like hand wash, hand hygiene procedure, biomedical waste disposal measures linked with caring for the infected patients. Still these patients are capable of spreading infection. The major cause of nosocomial infections are overcrowding of patients, unavailability of protective equipment and chemicals such PPE, disinfectant solution, improper use of sterilisation and disinfection criteria [1, 2].
Different Kinds of Nosocomial Infection Observed During Pandemic
Due to influence of SARS COV-2 pandemic nosocomial infections are commonly observed. As per a previous study, many patients complained regarding surgical site infection caused from catheter or Clostridium difficile infection. This condition made their situation more critical. Various kinds of infections related to nosocomial infections were observed such as urinary tract infection (UTI), Catheter associated urinary tract infection (CUTI), cold, cough, fever, bacterial meningitis, Staphylococcus aureus infection, Central line- associated bloodstream infection is one of them. As per previous reports it was increased. It will also lead to develop the antimicrobial resistance. Hospital based infections are the major cause for the infection, morbidity and mortality of healthcare facility staff as well as inmates [3, 4]. In case of organ damage lungs and kidneys are majorly affected organs during SARS COV-2, the diabetic and hypertensive patients are major sufferers [5]. Catheter associated UTI generally found in dialysis patients as per the reports major reason is the improper insertion of catheter. Majority of lungs infections cases reported due to combining effect of ventilator-associated conditions (VAC) with infection-related VAC. As the disease progresses and the patient’s respiratory condition worsen, the ventilator settings must be increased to prevent the above mention issues [6].
References
-
Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, et al. (2020) Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 382: 1708-1720.
-
Rothan HA, Byrareddy SN (2020) The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun 109: 102433.
-
McMullen KM, Smith BA, Rebmann T (2020) Impact of SARS-CoV-2 on hospital acquired infection rates in the United States: Predictions and early results. Am J Infect Control 48(11): 1409-1411.
-
Patel A, Jernigan DB, 2019-nCoV CDC Response Team (2020) Initial public health response and interim clinical guidance for the 2019 novel coronavirus outbreak − United States, December 31, 2019 − February 4, 2020. MMWR Morb Mortal Wkly Rep 69(5): 140-146.
-
Durvasula R, Wellington T, McNamara E, Watnick S (2020) Covid-19 and kidney failure in the acute care setting: our experience from Seattle. Am J Kidne Dis 76(1): 4-6.
-
Phua J, Weng L, Ling L, Egi M, Lim CM, et al. (2020) Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations. Lancet Respir Med 8(5): 506-517.
-
Ghelichkhani P, Esmaeili M (2020) Prone positioning in management of COVID-19 patients; a commentary. Arch Acad Emerg Med 8(1): e48.
-
WHO (2019) Therapeutics and COVID-19.
-
WHO guidelines for safe surgery 2009.
-
Coronavirus Disease 2019 (COVID-19) Treatment Guidelines.
- Antifungal Activity of New Acetophenone Derivatives
- Interconnected Microbiomes Human Health Within an Environmental Framework
- Silkworm-Based Vaccine Production for H5N1: A One Health Approach to Pandemic Preparedness
- Microbial Diversity and Lipolytic Activity of Bacteria and Fungi from Oil-Contaminated Sites in Makurdi Metroplois
- Antibiotic Resistance Profile of Bacteria Isolated at the Central Laboratory of the National Hospital Center of Nouakchott
- Epidemiology and Sensitivity to Antibiotics of Germs Isolated from Blood Cultures in the Laboratory of the National Hospital Center of Nouakchott-Mauritania